Farvid MS, Siassi F, Jalali M, Hosseini M. 2005. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 28:2458–2464.
Green H, Kehinde O. 1976. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7:105–113. 10.1016/0092-8674(76)90260-9
Gregoire FM, Smas CM, Sul HS. 1998. Understanding Adipocyte Differentiation. Physiol Rev 78:783–809.
Holman GD, Kasuga M. 1997. From receptor to transporter: insulin signalling to glucose transport. Diabetologia 40:991–1003. 10.1007/s001250050780
Kawada T, Aoki N, Kamei Y, Maeshige K, Nishiu S, Sugimoto E. 1990. Comparative investigation of vitamins and their analogues on terminal differentiation, from preadipocytes to adipocytes, of 3T3-L1 cells. Comp Biochem Physiol Part A Physiol. 96:323–326. doi:
http://dx.doi.org/10.1016/0300-9629(90)90699-S
Kiess W, Petzold S, Töpfer M, Garten A, Blüher S, Kapellen T, Kratzsch J. 2008. Adipocytes and adipose tissue. Best Pract Res Clin Endocrinol Metab 22:135–153. 10.1016/j.beem.2007.10.002
Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. 1983. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75:273–277.
Kodama M, Kodama T, Murakami M, Kodama M. 1993. Diabetes mellitus is controlled by vitamin C treatment. In Vivo 7:6A535–542.
May JM, Contoreggi CS. 1982. The mechanism of the insulin-like effects of ionic zinc. J BiolChem 257:4362–4368.
Mizuarai S, Miki S, Araki H, Takahashi K, Kotani H. 2005. Identification of dicarboxylate carrier Slc25a10 as malate transporter in de Novo fatty acid synthesis. J Biol Chem 280:32434–32441. 10.1074/jbc.M503152200
Nawrocki AR, Scherer PE. 2005. Keynote review: The adipocyte as a drug discovery target. DrugDiscovToday 10:1219–1230. 10.1016/S1359-6446(05)03569-5
Reitman ML, Arioglu E, Gavrilova O, Taylor SI. 2000. Lipoatrophy revisited. Trends Endocrinol Metabol 11:410–416. 10.1016/S1043-2760(00)00309-X
Rosen ED. 2005. The transcriptional basis of adipocyte development. Prostaglandins. Leukot. Essent Fatty Acids 73:31–34. 10.1016/j.plefa.2005.04.004
Ross SR, Graves RA, Greenstein A, Platt KA, Shyu HL, Mellovitz B, Spiegelman BM. 1990. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2
in vivo. Proc Natl Acad Sci USA 24:9590–9594.
Shang W, Yang Y, Jiang B, Jin H, Zhou L, Liu S, Chen M. 2007. Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARγ and C/EBPα gene expression. Life Sci 80:618–625. 10.1016/j.lfs.2006.10.021
Spiegelman BM. 1998. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507–514. 10.2337/diabetes.47.4.507
Spiegelman BM, Fliber JS. 1996. Adipogenesis and obesity: rounding out the big picture. Cell 87:377–389.
Spiegelman BM, Flier JS. 2001. Obesity and the regulation of energy balance. cell 104:531–543. 10.1016/S0092-8674(01)00240-9
Tang X-h, Shay NF. 2001. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-Kinase and akt in 3T3-L1 fibroblasts and adipocytes. J Nutr 131:1414–1420.
Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147–1156.
Ünaleroğlu C, Zümreoğlu-Karan B, Mert Y. 2002. Zinc ascorbate: a combined experimental and computational study for structure elucidation. J Mol Struct 605:227–233. 10.1016/S0022-2860(01)00765-7
Willson TM, Lambert MH, Kliewer SA. 2001. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem 70:341–367. 10.1146/annurev.biochem.70.1.341
Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, Spiegelman BM. 1999. Cross-tegulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3:151–158. doi:
http://dx.doi.org/10.1016/S1097-2765(00)80306-8
Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Kadowaki T. 2001. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 276:41245–41254. 10.1074/jbc.M103241200